Role of systems pharmacology in understanding drug adverse events.
about
Biomarker-based drug safety assessment in the age of systems pharmacology: from foundational to regulatory scienceStructure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive reviewMetabolomics and systems pharmacology: why and how to model the human metabolic network for drug discoveryExploring off-targets and off-systems for adverse drug reactions via chemical-protein interactome--clozapine-induced agranulocytosis as a case studySystematic prediction of pharmacodynamic drug-drug interactions through protein-protein-interaction networkSimvastatin Sodium Salt and Fluvastatin Interact with Human Gap Junction Gamma-3 ProteinToward an integrated software platform for systems pharmacologyHarnessing Big Data for Systems PharmacologySystematic identification of proteins that elicit drug side effectsMechanistic systems modeling to guide drug discovery and developmentDRAR-CPI: a server for identifying drug repositioning potential and adverse drug reactions via the chemical-protein interactomeiCTNet: a Cytoscape plugin to produce and analyze integrative complex traits networks.The primary glomerulonephritides: a systems biology approach.Finding novel pharmaceuticals in the systems biology era using multiple effective drug targets, phenotypic screening and knowledge of transporters: where drug discovery went wrong and how to fix it.ADReCS: an ontology database for aiding standardization and hierarchical classification of adverse drug reaction terms.CancerHSP: anticancer herbs database of systems pharmacology.Implementation of quantitative and systems pharmacology in large pharma.An integrative analysis of small molecule transcriptional responses in the human malaria parasite Plasmodium falciparumLogic-Based and Cellular Pharmacodynamic Modeling of Bortezomib Responses in U266 Human Myeloma Cells.Systems biology approaches for identifying adverse drug reactions and elucidating their underlying biological mechanisms.Mechanism-based pharmacodynamic modeling.The dynamics of signaling as a pharmacological target.Network pharmacology strategies toward multi-target anticancer therapies: from computational models to experimental design principles.Systems approaches in risk assessment.Use of Biomedical Ontologies for Integration of Biological Knowledge for Learning and Prediction of Adverse Drug Reactions.Systems engineering meets quantitative systems pharmacology: from low-level targets to engaging the host defenses.Needs for an expanded ontology-based classification of adverse drug reactions and related mechanisms.An overview of pharmacodynamic modelling, ligand-binding approach and its application in clinical practiceExamination and Estimation of Anticholinergic Burden: Current Trends and Implications for Future Research.Systems biology of cellular membranes: a convergence with biophysics.Adverse Drug Reactions for Medicines Newly Approved in Japan from 1999 to 2013: Hypertension and Hypotension.Chemogenomics knowledgebase and systems pharmacology for hallucinogen target identification-Salvinorin A as a case study.Network Pharmacology Strategies Toward Multi-Target Anticancer Therapies: From Computational Models to Experimental Design Principles.Mathematical modeling of efficacy and safety for anticancer drugs clinical development.Transcriptomics in kidney biopsy is an untapped resource for precision therapy in nephrology: a systematic review.Evidence-Based Precision Oncology with the Cancer Targetome.On the analysis of complex biological supply chains: From Process Systems Engineering to Quantitative Systems Pharmacology.Predicting adverse drug reaction profiles by integrating protein interaction networks with drug structures.Characterizing drug-related adverse events by joint analysis of biomedical and genomic data: A case study of drug-induced pulmonary fibrosis.Mechanism-based Pharmacovigilance over the Life Sciences Linked Open Data Cloud.
P2860
Q26778374-05E87D17-0A32-453A-ACB2-3E688A0A1220Q27008867-C8DB9F9E-4DA6-4383-BDB1-2D089B0BD0F2Q27144251-2138FDA2-92B6-470F-9C90-1E26B10E023EQ28477582-E3E451DE-6B9A-4267-BE8A-4D79A2087868Q28488578-5C6D9132-41D7-42B8-8626-323996A20C45Q28550067-135D0A35-A360-4418-811B-9A6DEBF29A43Q28650510-111E8E5C-17E2-4F05-B286-7346B910B9D8Q28969528-16B2A43C-5F7E-4B88-9F8A-4E5D559EDFEBQ30002377-2F6FD989-9CCC-4915-B1D6-F9246AA9BE3EQ30414988-7170688B-2838-4FA1-A963-0B6602974CB2Q33894409-AA51CD36-4237-4E80-B52A-0699C081BE94Q34029521-9C3B506D-FB45-493D-B921-71FBF24F8B6DQ34462626-9B4C8E2D-07CC-4BD0-B3A4-20C68D9F48BCQ34646772-DA723AB5-BC78-4F8B-A8AD-2B5D280CD37CQ35253481-D9E9BDA3-3C09-440B-B0CB-0707612B1A30Q35740846-493207FC-35ED-4231-93AB-F8B13EC9013CQ35760137-38ED559C-9D32-4FED-BF06-B717C49F7FF1Q35861261-9B2A722C-4B3A-4226-B14D-90235049731DQ35962054-84A7016D-34E6-4CD1-B2A0-A8D0CC9D7801Q36599215-9876633E-CECF-45A3-B9B4-F531C6CBA9C2Q36933670-93B99493-7ED0-42AA-BD4B-706C7BFA5F22Q37376115-D94EEF71-EEB7-49CF-B5B7-22FE4DB1390BQ38093187-77C41CAE-10F9-4CB4-9CF7-322AA3F26806Q38093360-2F292A0B-BC13-4424-81DE-EC320F85B104Q38370993-96A42C00-4D53-443C-8EA6-19F1C189A3D6Q38380621-0C13D660-F83B-4134-A456-AD91B9CBA26BQ38497041-C860B9A8-8DE9-4B5A-AD06-6B64600757C3Q38739512-A074E2C7-C9C7-4BD6-898C-1D0489F32E95Q38886942-86487763-9FE7-4C9A-B03B-AC3D1084EF27Q39285785-A2E08C7D-35CC-4A02-BF01-049A1732DAD0Q41313679-E96C0FCF-6393-48CC-9038-11A3C7397530Q43146252-7326908B-7154-48A2-B469-E6AB5D0E78C2Q47155086-66B5872A-E564-41EB-B6C8-550153D5A0CCQ47663303-E8D31DB0-3BD1-4C00-B2AA-295FCEB5DBCFQ47835456-C1B50F57-0166-497C-95AD-AFE7636A65BEQ47893147-3E4023D1-0CFD-41ED-9C71-AA1627799B1FQ49894254-5DF3BFD1-20C0-4A6B-9569-6B451C8D8ACBQ50734440-C4271B67-3F23-4533-8522-2414BF3E21FAQ55009284-CD5DE20C-1AD1-4E87-B37B-CB2BC55D9062Q55037586-BB6AECA3-BC28-485F-957D-E7CDDBF693F2
P2860
Role of systems pharmacology in understanding drug adverse events.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Role of systems pharmacology in understanding drug adverse events.
@ast
Role of systems pharmacology in understanding drug adverse events.
@en
Role of systems pharmacology in understanding drug adverse events.
@nl
type
label
Role of systems pharmacology in understanding drug adverse events.
@ast
Role of systems pharmacology in understanding drug adverse events.
@en
Role of systems pharmacology in understanding drug adverse events.
@nl
prefLabel
Role of systems pharmacology in understanding drug adverse events.
@ast
Role of systems pharmacology in understanding drug adverse events.
@en
Role of systems pharmacology in understanding drug adverse events.
@nl
P2860
P356
P1476
Role of systems pharmacology in understanding drug adverse events.
@en
P2093
Ravi Iyengar
P2860
P304
P356
10.1002/WSBM.114
P50
P577
2010-08-27T00:00:00Z